Genix Pharmaceuticals CorpTSXV:GENXView on OTCQB
- LAST PRICE0.0400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0400/ 76
- Ask / Lots0.0500/ 46
- Open / Previous Close--- / 0.0400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Genix Pharmaceuticals Corp | 2.4M | -0.6x | --- |
City View Green Holdings Inc | 1.8M | -0.8x | --- |
Lords & Company Worldwide Holdings Inc | 1.2M | -0.5x | --- |
Maven Brands Inc | 702.8K | 13.3x | --- |
Sweet Earth Holdings Corp | 620.1K | 2.1x | --- |
Biome Grow Inc | 558.0K | -0.3x | --- |
Company Information
Genix Pharmaceuticals Corporation is a life-sciences company. The Company is a formulator, manufacturer, licensor and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. The Company is focused on the research, development, manufacturing, licensing and selling of novel and healthcare products. These products include evidence-based, proprietary over the counter (OTC) nutraceuticals, and other single molecule generic drugs. The Company has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid soft gels, seal oil soft gels, marine lipid soft gels, Lecithin soft gels, fish oil soft gels, EPO soft gels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and Artificial Tearssingle-molecule.
Contact Information
- Headquarters
- Suite 300, 1055 West Hastings StVANCOUVER, BC, Canada V6E 2E9
- Phone
- 604-609-6198
- Fax
- 604-710-9461
Executives
- Independent Chairman of the Board
- Darryl Yea
- President, Director
- Mahmoud Aziz
- Chief Executive Officer, Director
- Sina Salehi Pirooz
- Chief Financial Officer
- Danny Lee
- Independent Director
- Kevin Bottomley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4M |
|---|---|
Revenue (TTM) | $4.0K |
Shares Outstanding | 59.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.55 |
EPS | $-0.07 |
Book Value | $-0.02 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 595.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -97,277.39% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
